Single-nucleotide polymorphism rs2070600 regulates AGER splicing and the sputum levels of the COPD biomarker soluble receptor for advanced glycation end-products.
- Publisher:
- European Respiratory Society (ERS)
- Publication Type:
- Journal Article
- Citation:
- ERJ Open Res, 2021, 7, (2), pp. 00947-02020
- Issue Date:
- 2021-04
Open Access
Copyright Clearance Process
- Recently Added
- In Progress
- Open Access
This item is open access.
The COPD susceptibility SNP rs2070600 affects the levels of the COPD biomarker sRAGE in sputum as well as splicing of AGER. Moreover, @PouwelsScience et al. demonstrate large differences in sRAGE levels between serum and sputum. https://bit.ly/3t0pJtK.
Please use this identifier to cite or link to this item: